Dexmedetomidine hydrochloride nasal spray + Dexmedetomidine hydrochloride nasal spray blank preparation.
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Preoperative Sedation
Conditions
Preoperative Sedation
Trial Timeline
Jan 6, 2020 → Aug 7, 2020
NCT ID
NCT04200235About Dexmedetomidine hydrochloride nasal spray + Dexmedetomidine hydrochloride nasal spray blank preparation.
Dexmedetomidine hydrochloride nasal spray + Dexmedetomidine hydrochloride nasal spray blank preparation. is a phase 1 stage product being developed by Jiangsu Hengrui Medicine for Preoperative Sedation. The current trial status is completed. This product is registered under clinical trial identifier NCT04200235. Target conditions include Preoperative Sedation.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04200235 | Phase 1 | Completed |
Competing Products
2 competing products in Preoperative Sedation
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| SHR0302 Base Gel + SHR0302 Base Gel Placebo | Jiangsu Hengrui Medicine | Phase 1 | 33 |
| dexmedetomidine nasal spray + dexmedetomidine hydrochloride nasal spray blank preparation | Jiangsu Hengrui Medicine | Phase 2/3 | 65 |